Kristen Ambrose Sells $347K of Vertex Pharmaceuticals Inc MA (VRTX) — SEC Form 4, Feb 28, 2023

Open-Market Net Sale · SEC Form 4

−$347,072

10b5-1 Plan

Equity position changed by -19.0%

Reporting Owner

Kristen Ambrose

CAO

TXN 2023-02-27 · FILED 2023-02-28

Equity Position 7.3K sh 9,012 → 7,303

Equity Change -19.0% shares held after vs before

Filing Lag 1 business day within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

Vertex Pharmaceuticals Inc MA

VRTX CIK 0000875320

Reporting Owner

Name	Relationship
Kristen Ambrose CIK 0001856587	CAO

Kristen Ambrose at Vertex Pharmaceuticals Inc MA Full insider history

Bought (12 mo) —

Sold (12 mo) $1,978,865

More from this insider at Vertex Pharmaceuticals Inc MA

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common Stock	2023-02-24	F - Tax Payment 10b5-1	502 D	$289.12	-$145,138	8,510	Direct
Common StockF1 F2 F3	2023-02-27	S - Sale 10b5-1	982 D	$287.25	-$282,080	7,528	Direct
Common StockF1 F2 F4	2023-02-27	S - Sale 10b5-1	183 D	$288.68	-$52,828	7,345	Direct
Common StockF1	2023-02-27	S - Sale 10b5-1	42 D	$289.63	-$12,164	7,303	Direct

Footnotes (4)

F1: Transaction made pursuant to Ms. Ambrose's company approved trading plan under Rule 10b5-1. Show more
F2: Ms. Ambrose undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Show more
F3: Open market sales reported on this line occurred at a weighted average price of $287.25 (range $286.79 to $287.71). Show more
F4: Open market sales reported on this line occurred at a weighted average price of $288.68 (range $288.24 to $289.17). Show more

Institutional Holders

Largest by reported value

5%+ Holders · 13D/G 3 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at Vertex Pharmaceuticals Inc MA

GET /v1/forms/4/0001209191-23-013695 API docs